Skip to main content
    O

    Ovid Therapeutics Inc (OVID)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.22
    -0.18 (-7.50%)

    Market Cap: $479.38M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Ovid Therapeutics Inc (OVID) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Ovid Therapeutics (OVID) has a latest price of $2.22 on Nov 17, 2026, 28.5% below its 52-week high of $3.10. Its price rose 70.1% over the past 12 months. The month-end price fell 80.1% since May 2017, a compound annual decline of 15.7%.

    Price Chart

    From May 2017 to Oct 2026, its highest month-end close was $12.75 in May 2017 and its lowest $0.27 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart OVID with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OVID.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 24.2%, and over 6 months it fell 7.5%. The month-end price fell 28.5% over the 3 years through Oct 2026, a compound annual decline of 10.6%.

    PeriodChange
    1 month+2.3%
    3 months-24.2%
    6 months-7.5%
    12 months+70.1%
    12 months, with dividends+70.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-28.5%-10.6%
    5 years-25.3%-5.7%
    Since May 2017-80.1%-15.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 74.6%, and its weakest was 2018, when it fell 75.5%.

    YearCloseChange
    2026 through Oct 2026$2.54+55.8%
    2025$1.63+74.6%
    2024$0.93-71.0%
    2023$3.22+73.1%
    2022$1.86-42.1%
    2021$3.21+39.0%
    2020$2.31-44.3%
    2019$4.15+71.5%
    2018$2.42-75.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 10.8% below its 50-day average of $2.49 and 8.3% below its 200-day average of $2.42.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.22
    52-week high$3.10-28.5%
    52-week low$1.21+83.5%
    50-day average$2.49-10.8%
    200-day average$2.42-8.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 93.7%.

    MeasureValue
    1-year beta1.46
    Largest fall, 1 year-27.4%
    Largest fall, 3 years-93.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About OVID

    What is OVID's 1-year price change?

    Ovid Therapeutics's price rose 70.1% over the past 12 months. With dividends included, the 12-month total return was 70.1%.

    What is OVID's 5-year price change?

    Ovid Therapeutics's month-end price fell 25.3% over the 5 years through Oct 2026, a compound annual decline of 5.7%. These figures leave out dividends.

    What is OVID's 52-week high and low?

    Ovid Therapeutics's 52-week high is $3.10 and its 52-week low is $1.21. Its latest price of $2.22 on Nov 17, 2026 is 28.5% below the high.

    What is OVID's beta?

    Ovid Therapeutics's 1-year beta against the S&P 500 is 1.46, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 27.4%.

    Is the OVID chart free?

    Yes. Advanced Charting for OVID is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.